Chondroitin sulfate is a key component of human joints. MyCondro™ is the world’s first non-animal chondroitin sulfate supporting joint health.
Chondroitin sulfate (CS) is a glycosaminoglycan, a natural substance produced by the body that is a component in human cartilage. It attracts water to the cartilage, offers shock absorption, and inhibits enzymes that degrade cartilage. This is why CS is widely used in dietary supplements to support joint health.
Today, the main source of CS used in dietary and pharmaceutical products is of animal origin (bovine, porcine, avian , and marine — including shark). However, animal-derived CS faces challenges of inconsistent quality and potential contamination, as well as ethical, religious, or dietary considerations, including allergy risks, that may restrict its use.
A non-animal alternative now exists. Fermentation-derived CS, MyCondro™, is an innovative, evidence-based alternative that combines superior bioavailability, safety, and proven efficacy with sustainability and clean-label credentials — a true game changer in joint health supplementation.
What is Fermentation-Derived Chondroitin Sulfate?
Fermentation Technology: A Breakthrough in Chondroitin Sulfate Production
A patented production technology utilizing micro-organism fermentation produces capsular polysaccharides identical to the chondroitin backbone.
This process uses the K4 capsular polysaccharide of Escherichia coli, a natural precursor for chondroitin. The process is followed by simple purification and hydrolysis of fructose residues. The result is a non-animal chondroitin called MyCondro™ from Gnosis by Lesaffre, which offers several distinct formulation advantages and benefits for consumers.
Key Characteristics of Fermentation-Derived Chondroitin Sulfate
Fermentation-derived chondroitin sulfate is characterized by a homogeneous profile and batch-to-batch consistency, as the fermentation process yields a uniform structure and physicochemical properties.
Production is highly controlled and reproducible, ensuring consistent quality. This novel fermentation process results in high-purity non-animal CS, with a chondroitin sodium sulfate content of more than 95%, exceeding the USP standard of 90%.
In addition, its low molecular weight (~9 kDa) enhances bioavailability.
It also offers an excellent safety profile: allergen-free, non-GMO, and with no concerns about the transmission of viruses or prions. It is suitable for vegan, vegetarian, and clean-label formulations.
The innovative production process and exclusive features of this ingredient are protected by five international patents.
Bioavailability and Efficacy Backed by Clinical Research
Superior Bioavailability of Fermentation-Derived Chondroitin Sulfate Versus Animal CS
Lower molecular weight (~9 kDa): The smaller molecular size of fermentation-derived chondroitin sulfate (CS) allows it to pass more easily through the intestinal wall, improving absorption efficiency.
Clinically proven higher bioavailability: Human pharmacokinetic studies show +45% bioavailability compared to bovine-derived pharma grade CS, meaning more of the active compound enters circulation after oral intake.
Enhanced tissue targeting: Higher concentrations in the bloodstream lead to more efficient delivery to joint tissues, supporting faster and more effective action for joint health.
Proven Efficacy of Fermentation-Derived Chondroitin Sulfate in Moderate Osteoarthritis (OA)
Effective and safe at a low dosage: Clinical studies have shown that just 600 mg of fermentation-derived chondroitin sulfate once daily delivers proven results, compared to the typical 800–1,200 mg per day required from animal-derived chondroitin sulfate.
Backed by two clinical trials: Its efficacy has been evaluated against placebo in individuals with moderate knee osteoarthritis (OA), confirming both its effectiveness and safety.
Demonstrated benefits: Supplementation has been shown to reduce knee pain, improve joint function and mobility, and decrease knee inflammation.
Benefits of Fermentation-Derived Chondroitin Sulfate for Joint Health Supplements
Meeting Consumer Demand for Clean-Label Joint-Support Nutraceuticals
Fermentation-derived chondroitin sulfate (CS) perfectly aligns with the growing demand for clean-label, ethical, and sustainable joint support nutraceuticals.
Vegan-friendly and allergen-free: Produced entirely without animal-derived raw materials, it is suitable for vegans, vegetarians, and consumers with dietary restrictions, while eliminating the risk of animal-protein-related allergies.
Sustainably sourced: It is obtained from microorganisms, a resource that is both exceptionally abundant and infinitely reproducible. This production method avoids pressure on marine ecosystems and significantly reduces the carbon footprint compared to extraction from animal tissues, most of which comes from intensive farming practices that are far less sustainable.
Eco-conscious and non-GMO positioning: It is well-suited for brands targeting “natural,” “non-GMO,” and “eco-conscious” markets, offering a strong alignment with modern consumer values.
Ethical advantages: It is 100% cruelty-free, directly addressing key ethical concerns associated with traditional animal-derived CS.
Consistency and Formulation Advantages of Fermentation-Derived CS
Fermentation-derived chondroitin sulfate offers a homogeneous structure, ensuring consistent quality and predictable performance.
It also provides high solubility and stability across multiple delivery formats, including capsules, tablets, powders, and liquids.
Its convenient dosage makes it ideal for pairing with complementary ingredients (such as Glucosamine, MSM, Collagen type 2, or other active ingredients for joint health).
Regulatory and Market Advantages
Fermentation-derived chondroitin sulfate (CS) offers strong regulatory credentials and clear competitive positioning for joint support nutraceuticals.
Recognized safety: Granted GRAS status (US FDA), Novel Food approved (EU), and TGA compliant, it is recognized as safe for use in dietary supplements across major global markets.
Facilitated market access: Regulatory acceptance in the US, EU, and AU helps simplify product registration and accelerate global launches.
Backed by clinical research and clean-label credentials: It enables brands to present themselves as innovators in a crowded joint-health segment.
Consumer trust: Regulatory recognition enhances credibility, reassuring health-conscious consumers and healthcare professionals alike.
Why This Innovation Matters Now ?
The global joint health supplement market is expanding rapidly, driven by rising consumer demand for effective, science-backed solutions.
At the same time, the prevalence of osteoarthritis is increasing, driven by an aging population and the growing impact of obesity worldwide.
In parallel, a wellness-oriented population engaging in more frequent and intense physical activity is also placing greater stress on joints, creating a growing need for supplementation with chondroitin sulfate such as MyCondro™.
Consumers are also paying closer attention to how ingredients are sourced, with greater scrutiny on ethics, sustainability, and environmental impact.
Fermentation-Derived CS: A Game-Changing Ingredient for Modern Joint-Health Nutraceuticals
Fermentation-derived chondroitin sulfate (CS) combines evidence-based benefits, superior bioavailability, and consistent quality, with the added advantage of sustainable, vegan-friendly, allergen-free sourcing. Unlike traditional animal-derived CS, it meets the growing demand for clean-label, eco-conscious dietary supplements without compromising performance.
Backed by clinical trial data in individuals with moderate knee osteoarthritis, this next-generation active ingredient offers a credible and safe option for supporting joint comfort, mobility, and cartilage health. Its unique production process reduces variability, ensures traceability, and eliminates the contamination risks associated with animal sources.
For supplement manufacturers, adopting fermentation-derived CS is a strategic opportunity to innovate, differentiate, and respond to consumers actively seeking ethical, science-backed solutions for overall joint health.
Do you need more information about MyCondro™ or have any outstanding questions? Please do not hesitate to contact us; our expert team will be happy to answer!
References :
- Volpi Nicola et al., Oral Bioavailability and Pharmacokinetics of Nonanimal Chondroitin Sulfate and Its Constituents in Healthy Male Volunteers, Clinical Pharmacology in Drug Development, Volume8, Issue3, April 2019, Pages 336-345.
- Rondanelli M et al. Effectiveness of non-animal chondroitin sulfate supplementation in the treatment of moderate knee osteoarthritis in a group of overweight subjects: a randomized, double-blind, placebo-controlled pilot study. Nutrients. 2019 Aug 29;11(9):2027. doi: 10.3390/nu11092027.
- Rondanelli M et al. Short- and Long-Term Effectiveness of Supplementation with Non-Animal Chondroitin Sulphate on Inflammation, Oxidative Stress and Functional Status in Obese Subjects with Moderate Knee Osteoarthritis before and after Physical Stress: A Randomized, Double-Blind, Placebo-Controlled Trial. Antioxidants (Basel) 2020 Dec 7;9(12):1241.doi: 10.3390/antiox9121241.
Discover MyCondro™
Chondroitin sulfate has been traditionally sourced from animals, but concerns over cross-contamination and manufacturing processes, as driven demand for a non-animal source of this key nutrient. Gnosis by Lesaffre is proud to fulfill this demand with its revolutionary ingredient MyCondro™.
